Nishiyama Yuki, Moriyama Muka, Fukamachi Masako, Uchida Arisa, Miyaushiro Hiromi, Kurata Ayumi, Tokoro Takashi, Ohno-Matsui Kyoko
Nippon Ganka Gakkai Zasshi. 2015 Nov;119(11):812-6.
Because highmyopia causes severe visual impairment, it is important to prevent the progression of myopia. Recently, the prevention of myopia progression by low dose atropine was reported from Singapore. We started the study of low dose atropine in Japanese children, with the aim of investigating the side effects of low dose atropine.
The participants were 16 children between the age of 6 and 12. They receive 0.01% atropine once nightly in both eyes. Refractive error, distant vision, near vision, accommodation and pupil diameter were checked before (baseline) and two weeks after the treatment (second baseline). Also, we checked subjective symptoms and adverse events.
There was no significant change between baseline and second baseline in the refractive error, distant vision, near vision. Accommodation decreased mean 1.5 D (p < 0.01) and the pupil diameter was mean 0.7 mm larger (p < 0.0001), but the subjective symptoms were minimal. Accommodation and pupil diameter showed significant changes. Severe subjective symptoms and adverse events were not found in any of the cases.
The side effects of low dose atropine were not severe. The treatment could be continued for the prevention of myopia.
由于高度近视会导致严重视力损害,预防近视进展很重要。最近,新加坡报道了低剂量阿托品可预防近视进展。我们开展了针对日本儿童的低剂量阿托品研究,旨在调查低剂量阿托品的副作用。
参与者为16名6至12岁的儿童。他们每晚双眼各滴入一次0.01%阿托品。在治疗前(基线)和治疗两周后(第二次基线)检查屈光不正、远视力、近视力、调节功能和瞳孔直径。此外,我们还检查了主观症状和不良事件。
在屈光不正、远视力、近视力方面,基线与第二次基线之间无显著变化。调节功能平均下降1.5 D(p < 0.01),瞳孔直径平均增大0.7 mm(p < 0.0001),但主观症状轻微。调节功能和瞳孔直径有显著变化。所有病例均未发现严重主观症状和不良事件。
低剂量阿托品的副作用不严重。该治疗可继续用于预防近视。